Burkitt's and Burkitt-like lymphoma. Molecular definition and value of the World Health Organisation's diagnostic criteria;Burkitt- und Burkitt-ähnliche lymphome. Molekulare definition und wertigkeit der diagnostischen WHO-kriterien

Pathologe

Volumn 28, Issue 1, 2007, Pages 41-45

  Stein, H ^a   Hummel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aggressiv B cell lymphomas; Gene expression profiling; Immunohistology; Molecular Burkitt lymphoma (mBL) signature index; Morphology; Sporadic B cell lymphomas

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MYC PROTEIN; PROTEIN BCL 6;

ARTICLE; BIOINFORMATICS; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; IMMUNOHISTOLOGY; MOLECULAR GENETICS; MORPHOLOGY; PROTEIN EXPRESSION; WORLD HEALTH ORGANIZATION;

BURKITT LYMPHOMA; COMPUTATIONAL BIOLOGY; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMANY; HUMANS; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 33847237655     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0884-4     Document Type: Article

References (11)

1. Coakley D (2006) Denis Burkitt and his contribution to haematology/oncology. Br J Haematol 135. 17-25
2. Diebold J, Jaffe ES, Raphael M, Warnke RA (2001) Burkitt Lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Tumours of the haematopoietic and lymphoid tissues. IARC, Lyon, pp 181-184
3. Gatter KC, Warnke RA (2001) Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Tumours of the haematopoietic and lymphoid tisuses. IARC, Lyon, pp 171-174
4. Magrath I, Jaffe ES, Bhatia K (2001) Burkitt's Lymphoma. In: Knowles DM (ed) Neoplastic hematopathology. Lippincott, Williams & Wilkins, pp 953-986
5. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89: 3909-3918
6. Pfreundschuh M, Trumper L, Kloess M et al. (2004) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 104: 634-641
7. Yeoh EJ, Ross ME, Shurtleff SA et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143
8. Rosenwald A, Wright G, Chan WC et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947
9. Hummel M, Bentink S, Berger H et al. (2006) A biological definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354: 2419-2430
10. Hecht JL, Aster JC (2000) Molecular biology of Burkitt's lymphoma. J Clin Oncol 18: 3707-3721
11. Boxer LM, Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene 20: 5595-5610